Who are Intervacc's investors?

Intervacc's investors include HealthCap.

Where is Intervacc headquartered?

Intervacc is headquartered in Stockholm, SE.

Intervacc

Stockholm, SE · 1 known investors

Find your way into Intervacc

Intervacc develops veterinary vaccines based on recombinant protein fusions. The company's lead product, Strangvac®, prevents strangles in horses, a serious and contagious global disease, and is available on several major European markets.

AgTech Biotech Healthtech Medical Devices

Founders & leadership

Jonas SohlmaninFounder

Investors · 1

HealthCapStockholm

In the news

Intervacc Awarded Funding From Vinnova For Further Development Of Vaccine Against Staphylococcus Aureus Infections | Reutersreuters.com · Mar 2020

BRIEF-Intervacc Awarded Funding From Vinnova For Further Development Of Vaccine Against Staphylococcus Aureus Infections | Reutersreuters.com · Mar 2020

Frequently asked questions

What does Intervacc do?: Intervacc develops veterinary vaccines based on recombinant protein fusions. The company's lead product, Strangvac®, prevents strangles in horses, a serious and contagious global disease, and is available on several major European markets.
Who are Intervacc's investors?: Intervacc's investors include HealthCap.
Where is Intervacc headquartered?: Intervacc is headquartered in Stockholm, SE.